Scientific work

Doç. Dr. Neslihan Demirel Öğüt

51 publications. The source of the information is stated next to each publication.

Back to profile

  1. Dysmenorrhea in Chronic Spontaneous Urticaria: A Subset of Patients Report Worsening and Partial Antihistamine Benefit: UCARE HURDLE-I Study

    International journal of dermatology, 2026

    DOI 10.1111/ijd.70252 PMID 41474111 Open-access full textSource: Europe PMC

  2. Malignancy burden and predictors in hidradenitis suppurativa tarda

    Journal of the European Academy of Dermatology and Venereology : JEADV, 2026

    DOI 10.1111/jdv.70715 PMID 42695529 Open-access full textSource: Europe PMC

  3. The Impact of Hidradenitis Suppurativa on Sexual Function: A Multicentered Cross‐Sectional Study

    International Journal of Dermatology, 2026

    DOI 10.1111/ijd.70522 PMID 42268671 Open-access full textSource: ORCID

  4. Caspase-8 Deficiency Unmasked by Refractory Psoriasiform Dermatitis: Marked Response to Dupilumab

    Dermatitis®, 2026

    DOI 10.1177/17103568261489011 PMID 42728888 Source: ORCID

  5. Authors' Reply: Dermatologists' Way of Informative Content on Dermatology and Cosmetology on Social Media

    Journal of Cosmetic Dermatology, 2026

    DOI 10.1111/jocd.71190 Open-access full textSource: ORCID

  6. Deucravacitinib in Psoriasis: Evidence, Gaps, and Place in Therapy

    International Journal of Dermatology, 2026

    DOI 10.1111/ijd.70170 PMID 41261382 Source: ORCID

  7. Predictors of relapse after omalizumab withdrawal in chronic spontaneous urticaria: Role of baseline autoimmunity and hematologic indices: CSU Relapse After Omalizumab Withdrawal

    Allergy and Asthma Proceedings, 2026

    DOI 10.2500/aap.2026.47.250089 PMID 41514184 Source: ORCID

  8. Assessing the Role of Baseline Creatine Kinase Measurement Before Initiating Oral Isotretinoin in Acne Vulgaris Patients: Insights From a Retrospective Cohort of 1256 Individuals

    Dermatologic Therapy, 2026

    DOI 10.1155/dth/2680904 Open-access full textSource: ORCID

  9. Hepatitis B Reactivation in Biologic‐Treated Moderate‐to‐Severe Psoriasis: A Real‐World Cohort Study With 534 Patient‐Years of Follow‐Up

    Dermatologic Therapy, 2026

    DOI 10.1155/dth/5653261 Open-access full textSource: ORCID

  10. Predictive Factors of Early Super-Response to Biologic Agents in Psoriasis: Insights from Real-World Evidence

    Clinical, cosmetic and investigational dermatology, 2026

    DOI 10.2147/ccid.s589513 PMID 41878550 Open-access full textSource: Europe PMC

  11. Evaluation of the Relationship Between Clinical Features of Acrochordons and Metabolic Syndrome Components: Prospective Cross-Sectional Study

    Turkiye Klinikleri Journal of Dermatology, 2026

    DOI 10.5336/dermato.2025-110831 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  12. A Cross-Sectional Study of Mycosis Fungoides Care: Diagnostic Challenges, Therapeutic Accessibility, and Resource-Adapted Solutions

    Turkish Journal of Dermatology, 2026

    DOI 10.4274/tjd.galenos.2026.41275 Open-access full textSource: OpenAlex

  13. Evaluation of Factors Associated with a History of Skin Cancer in Patients with Actinic Keratosis: AKASI as a Clinical Tool for Risk Stratification

    Turkish Journal of Dermatology, 2026

    DOI 10.4274/tjd.galenos.2026.65002 Open-access full textSource: OpenAlex

  14. New-Onset Pyoderma Gangrenosum in a Patient with Moderate-to-Severe Plaque Psoriasis on Ixekizumab Treatment: A Case Report and Review of the Literature

    Turkiye Klinikleri Journal of Dermatology, 2026

    DOI 10.5336/dermato.2025-111567 Open-access full textSource: OpenAlex

  15. The relationship between DLQI and DLQI-R scores and disease severity in patients with active psoriasis and chronic urticaria: a cross-sectional observational study

    Archives of Dermatological Research, 2026

    DOI 10.1007/s00403-026-04897-w Source: OpenAlex

  16. Alopecia areata management: Expert opinion report

    TURKDERM, 2026

    DOI 10.4274/turkderm.galenos.2026.16870 Open-access full textSource: OpenAlex

  17. Predictive factors for early super response to bimekizumab in 341 patients with psoriasis—a 24-week short-term multicenter real-life experience

    Journal of Dermatological Treatment, 2025

    DOI 10.1080/09546634.2025.2563657 PMID 41031572 4 citations (OpenAlex) Open-access full textSource: OpenAlex

  18. Serum C‐Reactive Protein as a Potential Indicator for Screening Fecal Calprotectin in Patients With Moderate‐to‐Severe Hidradenitis Suppurativa: A Cross‐Sectional Cohort Study

    International Journal of Dermatology, 2025

    DOI 10.1111/ijd.17868 PMID 40400092 Open-access full textSource: ORCID

  19. Monocyte-To-Lymphocyte Ratio May Be a Clue to Understand Underlying Cause of Pruritus in Chronic Kidney Disease

    Turkish Journal of Dermatology, 2025

    DOI 10.4274/tjd.galenos.2025.07108 Source: ORCID

  20. Dermatologists' Way of Informative Content About Dermatology and Cosmetology on Social Media

    Journal of Cosmetic Dermatology, 2025

    DOI 10.1111/jocd.70148 PMID 40689423 4 citations (Europe PMC) Open-access full textSource: ORCID

  21. Are IL-17 inhibitors superior to IL-23 inhibitors in reducing systemic inflammation in moderate-to-severe plaque psoriasis? A retrospective cohort study

    Archives of Dermatological Research, 2025

    DOI 10.1007/s00403-024-03768-6 PMID 39804473 9 citations (Europe PMC) Source: ORCID

  22. Structures of JAK Inhibitors

    Springer eBooks, 2025

    DOI 10.1007/978-3-031-84274-0_2 Source: ORCID

  23. A Multicenter Randomized Double-Blind Vehicle-Controlled Parallel Group Phase 2 Study Evaluating the Efficacy and Safety of GN-037 Cream in Patients with Mild-to-Moderate Plaque Psoriasis

    Dermatology and Therapy, 2024

    DOI 10.1007/s13555-024-01301-1 PMID 39578347 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  24. Do interleukin-17 and interleukin-23 inhibitors alter the coagulation parameters in psoriasis patients?: A retrospective study

    Archives of Dermatological Research, 2024

    DOI 10.1007/s00403-024-03369-3 PMID 39259347 1 citation (Europe PMC) Source: ORCID

  25. No association between isotretinoin and impulsivity in patients with moderate‐to‐severe acne vulgaris

    International Journal of Dermatology, 2024

    DOI 10.1111/ijd.16997 PMID 38140757 3 citations (Europe PMC) Open-access full textSource: ORCID

  26. Pain type and neuropathic pain components in acute herpes zoster

    Ağrı - The Journal of The Turkish Society of Algology, 2024

    DOI 10.14744/agri.2023.03743 PMID 38558392 1 citation (Europe PMC) Source: ORCID

  27. Evaluation of skin disease patterns in a tertiary dermatology outpatient clinic in Türkiye

    Health Sciences Quarterly, 2023

    DOI 10.26900/hsq.2052 Open-access full textSource: ORCID

  28. Two paradoxical reactions in a patient with psoriasis and psoriatic arthritis: Adalimumab‐induced hidradenitis suppurativa and secukinumab‐induced alopecia areata

    Journal of the European Academy of Dermatology and Venereology, 2023

    DOI 10.1111/jdv.18601 PMID 36151938 3 citations (Europe PMC) Source: ORCID

  29. Impulsivity in patients with acne excoriee

    Journal of Cosmetic Dermatology, 2023

    DOI 10.1111/jocd.15535 PMID 36409553 3 citations (Europe PMC) Open-access full textSource: ORCID

  30. Scabies Affects Quality of Life in Correlation with Depression and Anxiety

    Dermatology Practical & Conceptual, 2023

    DOI 10.5826/dpc.1302a144 PMID 37196304 19 citations (OpenAlex) Open-access full textSource: OpenAlex

  31. The effect of systemic therapies on hemogram parameters and C-reactive protein in patients with psoriatic arthritis

    TURKDERM, 2023

    DOI 10.4274/turkderm.galenos.2023.88614 2 citations (OpenAlex) Open-access full textSource: OpenAlex

  32. Ixekizumab treatment in patients with moderate‐to‐severe plaque psoriasis in a real‐world clinical setting

    Journal of Cosmetic Dermatology, 2022

    DOI 10.1111/jocd.15217 PMID 35801372 6 citations (Europe PMC) Source: ORCID

  33. Possible ruxolitinib‐induced acquired epidermodysplasia verruciformis and multiple non‐melanoma skin cancers in a patient with polycythemia vera

    Journal of Cosmetic Dermatology, 2022

    DOI 10.1111/jocd.15253 PMID 35866340 1 citation (Europe PMC) Source: ORCID

  34. Acquired plantar port‐wine stain (Fegeler syndrome) following prolonged standing

    Journal of Cosmetic Dermatology, 2022

    DOI 10.1111/jocd.14822 PMID 35106900 2 citations (Europe PMC) Source: ORCID

  35. Is dupilumab effective in adult‐onset atopic dermatitis: Real‐life experience of 16 patients

    Journal of Cosmetic Dermatology, 2022

    DOI 10.1111/jocd.14821 PMID 35100490 3 citations (Europe PMC) Source: ORCID

  36. Hidradenitis suppurativa and psoriasis coexistence in patients with Down syndrome: A case series

    Gulhane Medical Journal, 2022

    DOI 10.4274/gulhane.galenos.2021.67209 1 citation (OpenAlex) Open-access full textSource: ORCID

  37. A real life experience with ustekinumab: The effectiveness of 45 mg on patients greater than 80 kg but lower than 100 kg

    Dermatologic Therapy, 2022

    DOI 10.1111/dth.15494 PMID 35384189 Source: ORCID

  38. The role of online consultation requests to personal social media accounts and instant messaging services of dermatologists in occupational burnout: An emerging problem

    Journal of Cosmetic Dermatology, 2022

    DOI 10.1111/jocd.14417 PMID 34449960 4 citations (Europe PMC) Source: ORCID

  39. Evaluation of patients with telogen effluvium during the pandemic: May the monocytes be responsible for post COVID‐19 telogen effluvium?

    Journal of Cosmetic Dermatology, 2022

    DOI 10.1111/jocd.14883 PMID 35201647 8 citations (Europe PMC) Open-access full textSource: ORCID

  40. Retrospective evaluation of patients with chronic spontaneous urticaria using omalizumab during the COVID‐19 pandemic

    Journal of Cosmetic Dermatology, 2022

    DOI 10.1111/jocd.14725 PMID 34982508 6 citations (Europe PMC) Open-access full textSource: ORCID

  41. Dermatology consultation requests from a university hospital's pediatric and adult emergency departments: A 5-year retrospective analysis

    The American Journal of Emergency Medicine, 2022

    DOI 10.1016/j.ajem.2021.12.068 PMID 35016092 4 citations (Europe PMC) Source: ORCID

  42. Alterations of the human gut microbiome in patients with hidradenitis suppurativa: a case-control study and review of the literature

    Dermatology Practical & Conceptual, 2022

    DOI 10.5826/dpc.1204a191 PMID 36534543 13 citations (OpenAlex) Open-access full textSource: OpenAlex

  43. Trichotillomania, Skin Picking Disorder, and Different Aspects of Impulsivity: A Systematic Review

    Psychiatric Annals, 2022

    DOI 10.3928/00485713-20221220-02 4 citations (OpenAlex) Source: OpenAlex

  44. The effect of the COVID‐19 pandemic on dermatology consultation requests from adult and paediatric emergency departments

    International Journal of Clinical Practice, 2021

    DOI 10.1111/ijcp.14906 PMID 34553467 4 citations (Europe PMC) Open-access full textSource: ORCID

  45. Oral isotretinoin treatment in patients with acne vulgaris during the COVID‐19 pandemic: A retrospective cohort study in a tertiary care hospital

    Journal of Cosmetic Dermatology, 2021

    DOI 10.1111/jocd.14168 PMID 33884755 3 citations (Europe PMC) Open-access full textSource: ORCID

  46. The frequency and characteristics of itching in severe COVID‐19 patients: first report

    International Journal of Dermatology, 2021

    DOI 10.1111/ijd.15566 PMID 33830498 1 citation (Europe PMC) Open-access full textSource: ORCID

  47. Dermatologic comorbidities of the patients with severe COVID ‐19: A case‐control study

    Dermatologic Therapy, 2021

    DOI 10.1111/dth.14731 PMID 33389815 6 citations (Europe PMC) Open-access full textSource: ORCID

  48. Atypical mongolian spots as the initial manifestation of a lysosomal storage disorder

    Australasian Journal of Dermatology, 2020

    DOI 10.1111/ajd.13272 PMID 32173853 2 citations (Europe PMC) Source: ORCID

  49. Long-term effects of omalizumab on peripheral blood cells and C-reactive protein levels in patients with chronic spontaneous urticaria.

    Dermatologic therapy, 2019

    DOI 10.1111/dth.12966 PMID 31087491 9 citations (Europe PMC) Open-access full textSource: ORCID

  50. Hidradenitis Süpürativa Hastalarında Bağırsak Mikrobiyomunun İncelenmesi

    Hacettepe University Institutional Repository (hacettepe.edu.tr), 2019

    Source: OpenAlex